AAMU
SCMP

Amundi Asset Management US’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Amundi Asset Management US’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-22,000
Closed -$395K – 1637
2017
Q4 		$395K Buy
+22,000
New +$271K ﹤0.01% 1315

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Amundi Asset Management US's SCMP Position: Q1 2018 in Review

Amundi Asset Management US sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 22,000 shares — an estimated $395K sold.

Amundi Asset Management US first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $395K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Amundi Asset Management US reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Amundi Asset Management US sold 22,000 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $395K.
  • Amundi Asset Management US first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Amundi Asset Management US's Sucampo Pharmaceuticals, Inc. position peaked at $395K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Amundi Asset Management US's 13F filing for Q1 2018, filed 15 May 2018.